Statistics

Total Visits

Views
Bendamustine in combination with rituximab as first-line treatment for indolent non-hodgkin lymphoma: Retrospective analysis of An Spanish registry9

Select a period of time:

Number of views in the range

Views
Bendamustine in combination with rituximab as first-line treatment for indolent non-hodgkin lymphoma: Retrospective analysis of An Spanish registry5

Views

Views
November 20231
December 20230
January 20241
February 20240
March 20241
April 20240
May 20242
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States5
 

Top cities views

Views
Ashburn1
Boardman1
Chicago1
Fort Worth1